TRZ-32583-98418
2 vaccinations
3 coded responses
22 check-ins
4 free-text entries
3 call cases
- Sex
- Male
- Age at first dose
- 05-11
- ZIP prefix
- 024 / MA
- Registered
- 2021-11-04
- Relationship
- Child or adolescent in my care
- Guardian
- YA7-12587-14386
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-11-03
Dose 1 — Pfizer-BioNTech
-
2021-11-04
Registered in v-safe
-
2021-11-04
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Good · Site: Pain · NoneAdult check-in
- 2021-11-05
- 2021-11-06
- 2021-11-07
- 2021-11-09
- 2021-11-11
-
2021-11-17
Survey response — day 14, dose 1, dependentMedDRA: Ocular discomfort, Ocular hyperaemia, Swelling of eyelid — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Swollen lower eyelid with eye redness and discomfortMedDRA releases: 2024-11 · check-in free text available
-
2021-11-17
Report sent to call center — day 14, dose 1, dependentGet care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2021-11-19
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
-
2021-11-24
Dose 2 — Pfizer-BioNTech
- 2021-11-24
-
2021-11-25
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Fair · Site: Pain · NoneAdult check-in
-
2021-11-26
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Good · Site: Pain · NoneAdult check-in
- 2021-11-27
-
2021-11-28
Health check-in — days 1–6 daily, dose 2, dependentFeeling: GoodFree text: Burst blood vessel in eyeAdult check-in · check-in free text available
-
2021-11-29
Survey response — days 1–6 daily, dose 2, dependentMedDRA: Eye abrasion — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Eye abrasionMedDRA releases: 2024-11 · check-in free text available
-
2021-11-29
Report sent to call center — days 1–6 daily, dose 2, dependentGet care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-12-01
- 2021-12-03
- 2021-12-08
- 2021-12-08
- 2021-12-15
- 2021-12-22
- 2021-12-29
- 2022-01-05
- 2022-02-24
- 2022-05-25
-
2022-11-24
Survey response — 12 months, dose 2, dependentMedDRA: Nasopharyngitis — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: I have a coldMedDRA releases: 2024-11 · check-in free text available
-
2022-11-24
Report sent to call center — 12 months, dose 2, dependentGet care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-11-25
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-11-25
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-11-03 | Pfizer-BioNTech | No |
| 2 | 2021-11-24 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-11-17 | Successful 2021-11-19 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
| 2021-11-29 | Successful 2022-11-25 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
| 2022-11-24 | Successful 2022-11-25 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 10 — day 14, dose 1, dependent
Symptoms: Swollen lower eyelid with eye redness and discomfort
Release 10 — days 1–6 daily, dose 2, dependent
Systemic reaction (other): Eye abrasion
Release 12 — days 1–6 daily, dose 2, dependent
Systemic reaction (other): Burst blood vessel in eye
Release 12 — 12 months, dose 2, dependent
Symptoms: I have a cold
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Ocular discomfort | · | · | ✓ |
| SD | Ocular hyperaemia | · | · | ✓ |
| SD | Swelling of eyelid | · | · | ✓ |
| SRO | Eye abrasion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release